FindTrial
Sign In

Examination of safe apheresis implementation method

Construction of a highly safe leukocyte apheresis implementation system

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-jRCT1032210360
Enrollment
15
Registered
2021-10-02
Start date
2021-10-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases that require leukocyte apheresis

Interventions

Monitoring during apheresis

Sponsors

Yanagisawa Ryu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cases requiring leukocyte apheresis

Exclusion criteria

Exclusion criteria: (1) Patients for whom consent to participate in the research was not obtained (2) In addition, patients who were deemed inappropriate as a subject by the principal investigator

Design outcomes

Primary

MeasureTime frame
Search for appropriate monitoring methods to safely perform leukocyte apheresis.—

Contacts

Public ContactRyu Yanagisawa

Shinshu University Hospital

ryu@shinshu-u.ac.jp+81-263-37-3240

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026